Impact of NPF-Funded Research

The NPF has awarded over $20 million in research funding in recent years. 

This funding has provided support to undergraduate and graduate students, postdoctoral researchers, medical students and young doctors, and scientists, all with the goal of improving the lives of people with psoriatic disease. 

Two researchers looking at vials in a lab


While impact from NPF-funded research on the community and researchers is immeasurable, it has shown to yield over 6 times the return on investment. In 2013, the NPF provided an initial investment of $970,000, thanks to generous support from the NPF community. The researchers awarded funding at that time have continued on to receive awards from the National Institutes of Health (NIH) worth almost $7 million.

2019 Research Portfolio

NPF funded $2.8 million in research grants and fellowships in 2019, a record amount of funding that is expected to increase in subsequent years. 

Circle image of breakdown of 2019 funding image from pg 5 of the research portfolio

PsA Diagnostic Test Grant

NPF’s primary research goal is to lead collaborative, transformational research in psoriatic disease. As part of this goal, NFP introduced a new grant mechanism in 2019: The PsA Diagnostic Test Grant. This grant program, which aims to fund the development of a clinically applicable diagnostic test for psoriatic arthritis, has funded first-year, proof-of-concept proposals that have the potential to achieve our goal within five years. This research is continuing.

Psoriasis Prevention Initiative

Additionally, the National Psoriasis Foundation’s Psoriasis Prevention Initiative (PPI) aims to identify an intervention that will prevent the onset of psoriatic disease, disease relapse or relevant comorbidities, utilizing a multi-institution, multi-disciplinary, team-based research network. This research network will collaborate to address how to overcome the burden of psoriatic disease on patient's lives through prevention of disease.

Patient-Centered Research

Another avenue of NPF research is patient-centered research. In addition to Citizen Pscientist, where more than 5,400 patients share data, trends, and questions, NPF also conducts its Annual Survey. In 2019, the survey saw an almost seven-fold increase in response rates compared to previous years. As of early 2020, NPF has submitted four abstracts from survey findings and two have already been accepted; they are under review. The 2020 Society for Investigative Dermatology Annual Meeting accepted the two abstracts, which were written in collaboration with Joseph Merola, M.D., and Alice Gottlieb, M.D., Ph.D.

Join Our Mailing List

Get information and updates about our grants and fellowships program.

Sign up today

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2021 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.